Polysubstance use in treatment seekers who inject amphetamine: Drug use profiles, injecting practices and quality of life

Addictive Behaviors

Volumn 71, Issue , 2017, Pages 25-30

  Kelly, Peter J ^a   Robinson, Laura D ^a   Baker, Amanda L ^b   Deane, Frank P ^a   McKetin, Rebecca ^c   Hudson, Suzie ^d   Keane, Carol ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c CURTIN UNIVERSITY   (Australia)

^d Network of Alcohol and other Drugs Agencies (NADA)   (Australia)

Author keywords

Amphetamine; Drugs; Injecting; Latent class analysis; Mental health

Indexed keywords

ALCOHOL; AMPHETAMINE; DIAMORPHINE; OPIATE; CENTRAL STIMULANT AGENT;

ADULT; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DISTRESS SYNDROME; FEMALE; HELP SEEKING BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MENTAL HEALTH; MULTIPLE DRUG ABUSE; NEEDLE SHARING; QUALITY OF LIFE; SELF INJECTION; AMPHETAMINE DEPENDENCE; COMORBIDITY; DRUG DEPENDENCE; NEW SOUTH WALES; PSYCHOLOGY; RISK FACTOR; SUBSTANCE ABUSE;

ADULT; AMPHETAMINE; AMPHETAMINE-RELATED DISORDERS; CENTRAL NERVOUS SYSTEM STIMULANTS; COMORBIDITY; FEMALE; HUMANS; MALE; NEW SOUTH WALES; QUALITY OF LIFE; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS;

EID: 85013842767     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2017.02.006     Document Type: Article

References (37)

1. AIHW, Alcohol and other drugs (AODT-NMDS) data cubes. Closed treatment episodes: Client profile by drug of concern and treatment type by state/territory Australian Institute of Health and Welfare. Retrieved from http://www.aihw.gov.au/alcohol-and-other-drug-treatment-services-data-cubes/.2014, 2014.
2. AIHW, National drug strategy household survey. 2014 (Canberra).
3. Andrews, G., Slade, T., Interpreting scores on the Kessler Psychological Distress Scale (K10). Australian and New Zealand Journal of Public Health 25:6 (2001), 494–497.
4. Berlin, K.S., Williams, N.A., Gilber, R.P., An introduction to latent variable mixture modeling (part 1): Overview and cross-sectional latent class and latent profile analysis. Journal of Pediatric Psychology 39:2 (2014), 174–187.
5. Brecht, M.-L., O'Brien, A., von Mayrhauser, C., Anglin, M.D., Methamphetamine use behaviors and gender differences. Addictive Behaviors 29:1 (2004), 89–106.
6. Colfax, G., Coates, T.J., Husnik, M.J., Haung, Y., Buchbinder, S., Koblin, B., Al, E., Longitudinal patterns of amphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of San Francisco men who have sex with men. Journal of Urban Health 82:82(1 Suppl 1) (2005), i62–i70.
7. Connor, J.P., Gullo, M.J., Chan, G., Young, R.M., Hall, W., Feeney, G.F.X., Polysubstance use in cannabis users referred for treatment: Drug use profiles, psychiatric comorbidity and cannabis-related beliefs. Frontiers in Psychiatry, 2013, 10.3389/fpsyt.2013.00079.
8. Darke, S., Hall, W., Levels and correlates of polydrug use among heroin users and regular amphetamine users. Drug and Alcohol Dependence 39 (1995), 231–235.
9. Darke, S., Kaye, S., Ross, J., Transitions between the injection of heroin and amphetamines. Addiction 94:12 (1999), 1795–1803.
10. Darke, S., Kaye, S., McKetin, R., Duflou, J., Major physical and psychological harms of amphetamine use. Drug and Alcohol Review 27:3 (2008), 253–262.
11. Deady, M., A review of screening, assessment and outcome measures for drug and alcohol settings. 2009, Network of Alcohol and Other Drugs Agencies (NADA), Sydney.
12. Degenhardt, L., Hall, W., Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 379 (2012), 50–70.
13. Degenhardt, L., Day, C., Dietze, P., Pointer, S., Conroy, E., Collins, L., Al, E., Effects of a sustained heroin shortage in three Australian States. Addiction 100:7 (2005), 908–920.
14. Degenhardt, L., Mathers, B.M., Guarinieri, M., Panda, S., Phillips, B., Strathdee, S.A., Al, E., Meth/amphetamine use and associated HIV: Implications for global policy and public health. The International Journal on Drug Policy 21:5 (2010), 347–358.
15. Degenhardt, L., Larney, S., Dobbins, T., Chan, G., Weier, M., Roxburgh, A.E.A., Estimating the number of regular and dependent amphetamine users in Australia, 2002-2014. Medical Journal of Australia, 204(4), 2016.
16. Guydish, J., Passalacqua, E., Pagano, A., Martinez, C., Le, T., Chun, J., Al, E., An international systematic review of smoking prevalence in addiction treatment. Addiction 111:2 (2015), 220–230.
17. Hall, W., Hando, J., Darke, S., Ross, J., Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction 91:1 (1996), 81–87.
18. Hedden, S.L., Martins, S.S., Malcom, R.J., Floyd, L., Cavanaugh, C.E., Latimer, W.W., Patterns of illegal drug use among an adult alcohol dependent population: Results from the National Survey on Drug Use and Health. Drug and Alcohol Dependence 106 (2010), 119–125.
19. Horyniak, D., Stoové, M., Degenhardt, L., Aitken, C., Kerr, T., Dietze, P., How do drug market changes affect characteristics of injecting initiation and subsequent patterns of drug use? Findings from a cohort of regular heroin and methamphetamine injectors in Melbourne, Australia. The International Journal on Drug Policy 26:1 (2015), 43–50.
20. Hunt-Howard, K.E., An exploration of factors associated with methamphetamine injection among street-involved drug users and dealers in Los Angeles. Journal of Drug Issues 47:1 (2017), 4–24.
21. Kelly, P.J., Baker, A., Deane, F.P., Kay-Lambkin, F., Bonesvski, B., Tregarthen, J., Prevalence of smoking and other health risk factors in people attending residential substance abuse treatment. Drug and Alcohol Review 5 (2012), 638–644.
22. Kessler, R.C., Barker, P.R., Cople, L.J., Epstein, J.F., Gfroerer, J.C., Hiripi, E.E.,.. Zaslavsky, A.M., Screening for serious mental illness in the general population. Archives of General Psychiatry, 60(184–189), 2003.
23. Lanza, S.T., Patrick, M.E., Maggs, J.L., Latent transition analysis: Benefits of a latent variable approach to modeling transitions in substance use. Journal of Drug Issues 40:1 (2010), 93–120.
24. Lawrinson, D., Copeland, J., Indig, D., Development and validation of a brief instrument for routine outcome monitoring in opioid maintenance pharmacotherapy services: The brief treatment outcome measure (BTOM). Drug and Alcohol Dependence 80:1 (2005), 125–133.
25. Lynskey, M.T., Agrawal, A., Bucholz, K.K., Nelson, E.C., Madden, P.A.F., Todorov, A.A.,.. Heath, A.C., Subtypes of illicit drug users: A latent class analysis of data from an Australian twin sample. Twin Research and Human Genetics 9:4 (2006), 523–530.
26. Marsh, H.W., Ludtke, O., Trautwein, U., Morin, A.J.S., Classical latent profile analysis of academic self-concept dimensions: Synergy of person- and variable-centered approaches to theoretical models of self-concept. Structural Equation Modeling: A Multidisciplinary Journal 16:2 (2009), 191–225.
27. Marshall, B.D., Wood, E., Shoveller, J.A., Buxton, J.A., Montaner, J.S., Kerr, T., Individual, social, and environmental factors associated with initiating methamphetamine injection: Implications for drug use and HIV prevention strategies. Prevention Science 12:2 (2011), 173–180.
28. McKetin, R., Ross, J., Kelly, E., Baker, A., Lee, N., Lubman, D., Mattick, R., Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants. Drug and Alcohol Review 27:3 (2008), 277–285.
29. Pastor, D.A., Barron, K.E., Miller, B.L., Davis, S.L., A latent profile analysis of college students’ achievement goal orientation. Contemporary Educational Psychology 32:1 (2007), 8–47.
30. Quinn, B., Stoové, M., Papanastasiou, C., Dietze, P., Methamphetamine use in Melbourne, Australia: Baseline characteristics of a prospective methamphetamine-using cohort and correlates of methamphetamine dependence. Journal of Substance Use 18:5 (2013), 349–362.
31. Ritter, A., Stoove, M., Alcohol and other drug treatment policy in Australia. The Medical Journal of Australia, 204(4), 2016.
32. Schmidt, E., Muhlan, H., Power, M., The EUROHIS-QOL 8-item index: Psychometric results of a cross-cultural field study. The European Journal of Public Health 16:4 (2005), 420–428.
33. Sheridan, J., Butler, R., Wheeler, A., Initiation into methamphetamine use: Qualitative findings from an exploration of first time use among a group of New Zealand users. Journal of Psychoactive Drugs 41:1 (2009), 11–17.
34. Tait, R.J., McKetin, R., Kay-Lambkin, F., Bennett, K., Tam, A., Bennet, A.,.. Griffiths, K.M., Breaking the ice: A protocol for a randomised controlled trial of an internet-based intervention addressing amphetamine-type stimulant use. BMC Psychiatry, 12, 2012, 67.
35. The WHOQOL Group, Development of the WHOQOL: Rationale and current status. International Journal of Mental Health 23:3 (1994), 24–56.
36. Topp, L., Mattick, R.P., Choosing a cut-off on the severity of dependence scale (SDS) for amphetamine users. Addiction 92:7 (1997), 839–845.
37. UNODC, World drug report 2014. 2014, United Nations Office on Drugs and Crime, Vienna.